Chemed Corp (NYSE:CHE)
| 102.79 Data as of Jul 29 |  +0.48 / +0.47%Today’s Change | 64.16 Today|||52-Week Range 103.15 | +34.16% Year-to-Date |
Latest CHE News | Press Releases
| Insider Trading Alert - DPS, CHE And GPK Traded By Insiders Jul 29 / TheStreet.com | Frontrunning: July 24 Jul 24 / Investing Channel |
| Zacks Rank #1 Additions for Monday - Tale of the Tape Jul 28 / Zacks.com |
Today’s Trading
| Previous close | 102.31 |
| Today’s open | 102.00 |
| Day’s range | -- - -- |
| Volume | 211,209 |
| Average volume (3 months) | 222,296 |
| Market cap | $1.8B |
| Dividend yield | 0.78% |
Data as of 07/29/2014
Growth & Valuation
| Earnings growth (last year) | -9.96% |
| Earnings growth (this year) | +5.84% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -1.17% |
| P/E ratio | 21.9 |
| Price/Sales | 0.99 |
| Price/Book | 4.03 |
Financials
| Last reporting date | July 23, 2014 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $1.4B |
| Annual profit (last year) | $77.2M |
| Net profit margin | 5.46% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
President, Chief Executive Officer & Director Kevin J. McNamara |
Chief Financial Officer & Executive Vice President David Patrick Williams |
Corporate headquarters Cincinnati, Ohio |
Forecasts
.
